{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:27:54Z","timestamp":1771662474882,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0513-1","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T10:28:50Z","timestamp":1431426530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Werner","family":"Dammermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Bentzien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Maria","family":"Stiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"K\u00fchne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian Schulze","family":"zur Wiesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"L\u00fcth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,13]]},"reference":[{"issue":"12","key":"513_CR1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212\u20139.","journal-title":"Vaccine"},{"issue":"2","key":"513_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.coi.2010.12.013","volume":"23","author":"LM Huang","year":"2011","unstructured":"Huang LM, Lu CY, Chen DS. Hepatitis B virus infection, its sequelae, and prevention by vaccination. Curr Opin Immunol. 2011;23(2):237\u201343.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"513_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12250-014-3410-5","volume":"29","author":"J Liu","year":"2014","unstructured":"Liu J, Kosinska A, Lu M, Roggendorf M. New therapeutic vaccination strategies for the treatment of chronic hepatitis B. Virol Sin. 2014;29(1):10\u20136.","journal-title":"Virol Sin"},{"issue":"4","key":"513_CR4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0168-8278(03)00292-7","volume":"39","author":"C Boni","year":"2003","unstructured":"Boni C, Penna A, Bertoletti A, Lamonaca V, Rapti I, Missale G, et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol. 2003;39(4):595\u2013605.","journal-title":"J Hepatol"},{"issue":"4","key":"513_CR5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","volume":"143","author":"C Boni","year":"2012","unstructured":"Boni C, Laccabue D, Lampertico P, Giuberti T, Vigano M, Schivazappa S, et al. Restored function of HBV-Specific T Cells after Long-term effective therapy with Nucleos(t)ide Analogues. Gastroenterology. 2012;143(4):963\u201373.","journal-title":"Gastroenterology"},{"issue":"4","key":"513_CR6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/erv.10.162","volume":"10","author":"C Cooper","year":"2011","unstructured":"Cooper C, Mackie D. Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV safety and efficacy. Expert Rev Vaccines. 2011;10(4):417\u201327.","journal-title":"Expert Rev Vaccines"},{"key":"513_CR7","doi-asserted-by":"crossref","first-page":"9(7)","DOI":"10.4161\/hv.24256","volume":"9","author":"SA Halperin","year":"2013","unstructured":"Halperin SA, Ward BJ, Dionne M, Langley JM, McNeil SA, Smith B, et al. Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine. Hum Vaccin Immunother. 2013;9:9(7).","journal-title":"Hum Vaccin Immunother"},{"issue":"51","key":"513_CR8","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1016\/j.vaccine.2007.09.072","volume":"25","author":"P Vandepapeliere","year":"2007","unstructured":"Vandepapeliere P, Lau GK, Leroux-Roels G, Horsmans Y, Gane E, Tawandee T, et al. Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg\/AS02 candidate vaccine and lamivudine. Vaccine. 2007;25(51):8585\u201397.","journal-title":"Vaccine"},{"issue":"7","key":"513_CR9","volume":"3","author":"DZ Xu","year":"2008","unstructured":"Xu DZ, Zhao K, Guo LM, Li LJ, Xie Q, Ren H, et al. A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. PLoS One. 2008;3(7), e2565.","journal-title":"PLoS One"},{"issue":"12","key":"513_CR10","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1128\/AAC.00276-09","volume":"53","author":"PT Hoa","year":"2009","unstructured":"Hoa PT, Huy NT, Thu lT, Nga CN, Nakao K, Eguchi K. Randomized controlled study investigating viral suppression and serological response following pre-S1\/pre-S2\/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B. Antimicrob Agents Chemother. 2009;53(12):5134\u201340.","journal-title":"Antimicrob Agents Chemother"},{"issue":"39","key":"513_CR11","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1016\/j.vaccine.2014.07.027","volume":"32","author":"A Gaggar","year":"2014","unstructured":"Gaggar A, Coeshott C, Apelian D, Rodell T, Armstrong BR, Shen G, et al. Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study. Vaccine. 2014;32(39):4925\u201331.","journal-title":"Vaccine"},{"issue":"39","key":"513_CR12","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1016\/j.vaccine.2014.06.076","volume":"32","author":"A Krawczyk","year":"2014","unstructured":"Krawczyk A, Ludwig C, Jochum C, Fiedler M, Heinemann FM, Shouval D, et al. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS\/S vaccine. Vaccine. 2014;32(39):5077\u201382.","journal-title":"Vaccine"},{"issue":"5","key":"513_CR13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2005.08.058","volume":"24","author":"T Bauer","year":"2006","unstructured":"Bauer T, Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine. 2006;24(5):572\u20137.","journal-title":"Vaccine"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-015-0513-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0513-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:41:02Z","timestamp":1553640062000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,13]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0513-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,13]]},"article-number":"157"}}